false000163605000016360502021-11-012021-11-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
- Designation complements previously granted Rare Pediatric Disease and Orphan Drug designations- ...
NEW YORK and DURHAM, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a...
By Colin Kellaher Sio Gene Therapies Inc. on Thursday said the U.S. Food and Drug Administration granted fast-track designation to AXO-AAV-GM1 in...
Consistent dose-dependent improvements across biomarker measuresNormalization of serum beta-galactosidase...
As filed with the Securities and Exchange Commission on October 6, 2021 Registra...
NEW YORK, and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a...
NEW YORK and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a...
false000163605000016360502021-09-232021-09-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc...
- Study has now enrolled a total of nine patients across low-dose and high-dose cohorts- On track to report...
false000163605000016360502021-08-122021-08-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
0001636050false3/312022Q1.50.5033.3300016360502021-04-012021-06-30xbrli:shares00016360502021-08-10iso4217:US...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.